The Future of Heart Failure Diagnosis, Therapy, and Management-Reference-Cited by-同舟云学术

The Future of Heart Failure Diagnosis, Therapy, and Management

Published:2016-06-21 Issue:25 Volume:133 Page:2671-2686
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Udelson James E.¹,Stevenson Lynne Warner¹

Affiliation:

1. From Division of Cardiology and the Cardiovascular Center, Tufts Medical Center, Boston, MA (J.E.U.); and Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston MA (L.W.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference121 articles.

1. Centers for Disease Control and Prevention National Center for Health Statistics. 2010 National Ambulatory Medical Care Survey and 2010 National Hospital Ambulatory Medical Care Survey. For methodology see National Center for Health Statistics Public Use Data File Documentation: 2010 National Ambulatory Medical Care Survey and Public Use Data File Documentation: 2010 National Hospital Ambulatory Medical Care Survey. http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm. Accessed January 9 2016.

2. Heart Disease and Stroke Statistics—2015 Update

3. Forecasting the Impact of Heart Failure in the United States

4. Long-Term Trends in the Incidence of and Survival with Heart Failure

5. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The JMJD family of histone demethylase and their intimate links to cardiovascular disease;Cellular Signalling;2024-04

2. Electrochemical immunosensor for the quantification of galectin-3 in saliva;Sensors and Actuators B: Chemical;2024-02

3. Promising New Horizons in Medicine: Medical Advancements with Nanocomposite Manufacturing via 3D Printing;Polymers;2023-10-17

4. A review of current key guidelines for managing high‐risk patients with diabetes and heart failure and future prospects;Diabetes, Obesity and Metabolism;2023-05-30

5. Low incidence of cardiotoxicity in patients with non‐Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure;European Journal of Haematology;2023-04